Skip to content

IP3R drives cardiomyocyte injury by enhancing MAM-mediated Ca2+ transfer and mitochondrial dysfunction.

Aug 2026 · Molecular and Cellular Endocrinology · Vol 622, pp. 112880 · 0 citations · 40 references
Medicine

TL;DR

Findings suggest that IP3R may exacerbate cardiomyocyte injury by facilitating MAM-mediated Ca2+ transfer and mitochondrial dysfunction, indicating that targeting IP3R could represent a potential therapeutic strategy for HF.

Abstract

Background

Heart failure (HF) is the terminal stage of various cardiovascular diseases. Mitochondrial Ca2+ overload and dysfunction mediated by mitochondria-associated ER membranes (MAMs) are recognized contributors to HF pathogenesis; however, the underlying molecular mechanisms remain incompletely understood.

Methods

An in vitro model of cardiomyocyte injury was established using angiotensin II (Ang II)-stimulated H9c2 cells. IP3R was knocked down using specific siRNA. Cell viability (CCK-8), apoptosis (Annexin V/TUNEL), and hypertrophy (phalloidin staining) were assessed. IP3R expression and mitochondrial complex subunits were analyzed by western blotting. MAM formation was examined by transmission electron microscopy and immunofluorescence co-localization. Mitochondrial function was evaluated by measuring ATP levels, ROS (MitoSOX), mitochondrial membrane potential (TMRM), and Ca2+ uptake (Rhod-2).

Results

Ang II stimulation reduced cell viability, induced hypertrophy and apoptosis, and promoted MAM formation. Mechanistically, Ang II upregulated IP3R expression and enhanced MAM-mediated mitochondrial Ca2+ overload, leading to decreased mitochondrial membrane potential, elevated ROS, and reduced ATP production. Notably, genetic knockdown of IP3R attenuated these pathological changes, reducing MAM formation and mitochondrial Ca2+ overload while restoring mitochondrial function and cell viability.

Conclusion

Our findings suggest that IP3R may exacerbate cardiomyocyte injury by facilitating MAM-mediated Ca2+ transfer and mitochondrial dysfunction, indicating that targeting IP3R could represent a potential therapeutic strategy for HF. However, the upstream mechanisms of IP3R upregulation and the causal role of mitochondrial Ca2+ uptake require further investigation.

View source

Similar papers

Sep 2026

Non-canonical modulation of mitochondrial ROS and dynamics by Netrin-3 drives inflammasome activation in cardiomyocytes.

Observations support a model in which Netrin-3 participates in coupling inflammasome signaling to mitochondrial alterations through a ROS-dependent route, and whether Netrin-3 inhibition has therapeutic value in heart failure warrants further investigation.

Biao Li, Hao-Yang Ge, Xi-Wei Chen et al. · 0 citations
Sep 2026

Src tyrosine kinase mediates Zn2+-induced myocardial protection against endoplasmic reticulum stress and ischemia/reperfusion injury.

OBJECTIVE To investigate the role of Src tyrosine kinase in Zn2+-induced cardioprotection and the mechanisms involving endoplasmic reticulum stress (ERS), mitochondrial dysfunction, and mitochondrial calcium regulation. METHODS H9c2 cells were used to establish in vitro models of ischemia/reperfusion (I/R) injury and...

Xiao-Yi Li, Yu Fu, Zhi-Jia Shen et al. · 0 citations
Open access Oct 2026

WTAP-induced upregulation of KDR ameliorates angiotensin II-induced apoptosis, oxidative stress and ferroptosis of human brain microvascular endothelial cells

Intracranial aneurysms (IAs) are a significant cause of morbidity and mortality, often leading to subarachnoid hemorrhage and subsequent neurological deficits. The kinase insert domain receptor (KDR) plays a crucial role in vascular cell function during IA. However, the mechanism responsible for KDR’s role in IA remain...

Y. Shao, Zheng-Xiang Yang, Yi Pu et al. · 0 citations
Open access Aug 2026

CARD10 deficiency attenuates myocardial infarction associated with enhanced cardiac fibroblast senescence

It is suggested that CARD10 deficiency is associated with enhanced fibroblast senescence and improved post-MI remodeling, potentially involving mitochondrial dysfunction and PI3K/AKT signaling, highlighting CARD10 may represent a promising target for the treatment of MI.

Yueyue Xu, Yiwei Yao, Yue-Yun Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.